Body Systems

Uveitis3 Results found

Studies recruiting participants:

Closed for recruitment:

A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis (VISUAL III)

There is an unmet medical need in non-infectious intermediate-, posterior- and pan uveitis. These types of uveitis are at a higher risk for vision loss compared to anterior uveitis. Patients with these types of uveitis are often treated with chronic corticosteroids.

Closed for Recruitment
Principal Investigator 
Patrick Ma
Body Locations and Systems 
Uveitis
Area 
Vancouver
Age 
18-99